Actively Recruiting

Age: 18Years +
All Genders
ID06552078

Activation of Biobank for Association Study Between Environmental and Genetic Factors in Inflammatory, Functional and Neoplastic Bilio-pancreatic Diseases

Led by IRCCS San Raffaele · Updated on 2025-05-02

2000

Participants Needed

1

Research Sites

156 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating the role of genetic predisposition and environmental factors in multifactorial bilio-pancreatic diseases, including inflammatory, functional, and neoplastic conditions such as pancreatitis and pancreatic adenocarcinoma. The study aims to better understand how these combined factors contribute to disease development for improved prevention and early diagnosis. This observational study is sponsored by IRCCS San Raffaele and collects both retrospective and prospective biological samples and clinical data. Participants provide various biological samples depending on their condition, including peripheral and portal blood, saliva, urine, stool, cystic fluid, pancreatic juice, and biopsy tissues. The biobank collects and stores these samples to facilitate analysis of genetic and environmental influences on bilio-pancreatic diseases. There is no treatment or intervention administered, as this is an observational study. During the study, researchers collect and analyze clinical data and biological samples to measure the rate of patients with pancreatic disorders who show specific exposures or biomarkers. The study lasts about one year on average, with ongoing monitoring through study completion. Participants' involvement includes providing consent and samples, with no additional treatment or procedures required.

CONDITIONS

Brief Title

Activation of Biobank Registry for Bilio-pancreatic Diseases

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Younger than 18 years
  • Unwilling to sign informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Sample Collection

Duration - Up to 1 year

Participants provide various biological samples depending on their disease, including blood, saliva, urine, stool, cystic fluid, pancreatic juice, and biopsy tissue specimens.

Visits as needed for sample collection over the study period

Long-term Monitoring

Duration - Up to study completion (approximately 3 years)

Participants are observed for disease progression and exposure to certain biomarkers over the course of the study.

Follow-up visits depending on participant status and disease progression

Trial Site Locations

Total: 1 location

1

IRCCS OSpedale San Raffaele

Milan, Italy, 20132

Actively Recruiting

Loading map...

Research Team

G

Gabriele Capurso, MD

L

Laura Apadula, MSN

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

9-ING-41 (Elraglusib) Combined With Retifanlimab and Modifie...

Pancreatic Adenocarcinoma

Actively Recruiting

1 location

A Feasibility and Safety Study of Intratumoral Diffusing Alp...

Pancreatic Cancer

Actively Recruiting

2 locations

A Phase 1, Open-label, Dose-escalation and Cohort Expansion ...

Solid Tumours

Actively Recruiting

10 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here